Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > EBIT

Iovance Biotherapeutics Inc EBIT Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Iovance Biotherapeutics Inc EBIT for the quarter ending September 09, 2020 was $-59m a -10.42% increase of 6m year over year
  • Iovance Biotherapeutics Inc EBIT for the last 12 months ending September 09, 2020 was $-259m a 19.98% decrease of -52m year over year
  • Iovance Biotherapeutics Inc Annual EBIT for 2019 was $-207m a 38.00% decrease of -79m from 2018
  • Iovance Biotherapeutics Inc Annual EBIT for 2018 was $-128m a 27.59% decrease of -35m from 2017
  • Iovance Biotherapeutics Inc Annual EBIT for 2017 was $-93m a 52.48% decrease of -49m from 2016
Other Income Statement Metrics:
  • Iovance Biotherapeutics Inc EBITDA for the quarter ending December 12, 2018 was $-35m a 23.18% decrease of -8m year over year
  • Iovance Biotherapeutics Inc Net Income for the quarter ending December 12, 2018 was $-33m a 18.60% decrease of -6m year over year
View Chart On Koyfin

Quarterly IOVA EBIT Data

09/2020$-59m
06/2020$-64m
03/2020$-71m
12/2019$-65m
09/2019$-52m
06/2019$-50m
03/2019$-40m
12/2018$-35m
09/2018$-35m
06/2018$-31m

Annual IOVA EBIT Data

2019$-207m
2018$-128m
2017$-93m
2016$-44m
2015$-28m
2014$-12m
2013$-6m
2012$-8m
2011$-21m
2010$-1m